×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
GPCR – structure therapeutics inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
GPCR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/29
05:16 pm
gpcr
Structure Therapeutics Phase 2 Obesity Data Shifts Focus To Phase 3 [Yahoo! Finance]
Medium
Report
Structure Therapeutics Phase 2 Obesity Data Shifts Focus To Phase 3 [Yahoo! Finance]
3/28
01:05 am
gpcr
Structure Therapeutics (GPCR) was downgraded by Wall Street Zen from
Medium
Report
Structure Therapeutics (GPCR) was downgraded by Wall Street Zen from
3/26
09:00 am
gpcr
Structure Therapeutics (GPCR) is now covered by Wolfe Research. They set a "peer perform" rating on the stock.
Medium
Report
Structure Therapeutics (GPCR) is now covered by Wolfe Research. They set a "peer perform" rating on the stock.
3/23
11:13 am
gpcr
Structure Therapeutics CEO on the company's oral GLP-1 opportunity [CNBC]
Medium
Report
Structure Therapeutics CEO on the company's oral GLP-1 opportunity [CNBC]
3/22
04:37 pm
gpcr
Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges [Yahoo! Finance]
Low
Report
Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges [Yahoo! Finance]
3/18
12:30 am
gpcr
Structure Therapeutics Posts 15%+ Weight Loss in ACCESS II for Oral GLP-1 Aleniglipron, Eyes Phase III [Yahoo! Finance]
Medium
Report
Structure Therapeutics Posts 15%+ Weight Loss in ACCESS II for Oral GLP-1 Aleniglipron, Eyes Phase III [Yahoo! Finance]
3/17
01:11 pm
gpcr
Structure Therapeutics (GPCR) was given a new $145.00 price target by BMO Capital Markets. They now have an "outperform" rating on the stock.
Low
Report
Structure Therapeutics (GPCR) was given a new $145.00 price target by BMO Capital Markets. They now have an "outperform" rating on the stock.
3/17
07:48 am
gpcr
Structure Therapeutics' GLP-1 Agonist Could Be A Potential Acquisition Target [Seeking Alpha]
Low
Report
Structure Therapeutics' GLP-1 Agonist Could Be A Potential Acquisition Target [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/23
04:31 pm
gpcr
Form 4 Structure Therapeutics For: Mar 19 Filed by: Hall Ashley
Medium
Report
Form 4 Structure Therapeutics For: Mar 19 Filed by: Hall Ashley
3/23
04:30 pm
gpcr
Form 4 Structure Therapeutics For: Mar 19 Filed by: Coll Crespo Blas
Medium
Report
Form 4 Structure Therapeutics For: Mar 19 Filed by: Coll Crespo Blas
3/23
04:30 pm
gpcr
Form 4 Structure Therapeutics For: Mar 19 Filed by: Lin Xichen
Medium
Report
Form 4 Structure Therapeutics For: Mar 19 Filed by: Lin Xichen
3/23
04:30 pm
gpcr
Form 4 Structure Therapeutics For: Mar 19 Filed by: Yoon Jun
Medium
Report
Form 4 Structure Therapeutics For: Mar 19 Filed by: Yoon Jun
3/23
04:30 pm
gpcr
Form 4 Structure Therapeutics For: Mar 19 Filed by: Ma Yingli
Medium
Report
Form 4 Structure Therapeutics For: Mar 19 Filed by: Ma Yingli
3/23
04:30 pm
gpcr
Form 4 Structure Therapeutics For: Mar 19 Filed by: Stevens Raymond C
Medium
Report
Form 4 Structure Therapeutics For: Mar 19 Filed by: Stevens Raymond C
3/16
08:01 am
gpcr
Form 8-K Structure Therapeutics For: Mar 16
Medium
Report
Form 8-K Structure Therapeutics For: Mar 16
3/5
06:21 pm
gpcr
Form 4 Structure Therapeutics For: Mar 03 Filed by: Coll Crespo Blas
Low
Report
Form 4 Structure Therapeutics For: Mar 03 Filed by: Coll Crespo Blas
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: